ACADIA Pharmaceuticals
ACAD
#4235
Rank
C$4.02 B
Marketcap
C$23.29
Share price
-22.28%
Change (1 day)
-25.30%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2026 (TTM): C$0.16 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are C$1.13 Billion. In 2025 the company made an earning of C$0.19 Billion a decrease over its 2024 earnings that were of C$0.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.16 B-13.45%
2025 C$0.19 B-46.18%
2024 C$0.36 B-605.67%
2023 -C$72.04 Million-76.09%
2022 -C$0.31 Billion27.41%
2021 -C$0.24 Billion-40.38%
2020 -C$0.4 Billion19.88%
2019 -C$0.34 Billion-3.92%
2018 -C$0.35 Billion-15.04%
2017 -C$0.41 Billion6.33%
2016 -C$0.39 Billion64.55%
2015 -C$0.24 Billion77.47%
2014 -C$0.14 Billion143.69%
2013 -C$53.56 Million81.93%
2012 -C$29.44 Million-8.73%
2011 -C$32.26 Million-251.39%
2010 C$21.3 M-133.2%
2009 -C$64.18 Million-30.82%
2008 -C$92.77 Million6.43%
2007 -C$87.17 Million25.89%
2006 -C$69.24 Million36.99%
2005 -C$50.54 Million37.22%
2004 -C$36.84 Million19.96%
2003 -C$30.71 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.42 B 15,324.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$9.74 B 5,590.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$49.07 B 28,547.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$15.99 B 9,236.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-C$0.27 Billion-252.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-C$54.53 Million-131.83%๐Ÿ‡บ๐Ÿ‡ธ USA